Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Crohn's Disease market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 1.8% during the forecast period.
This report presents the market size and development trends by detailing the Crohn's Disease market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Crohn's Disease market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Crohn's Disease industry and will help you to build a panoramic view of the industrial development.
Crohn's Disease Market, By Type:
Aminosalicylates
Corticosteroids
Immunomodulators
Crohn's Disease Market, By Application:
Ileocolitis
lleitis
Gastroduodenal Crohn’s disease
Jejunoileitis
Crohn colitis
Others
Some of the leading players are as follows:
Johnson & Johnson
Perrigo Company plc
UCB
Takeda Pharmaceuticals.
Prometheus Laboratories Inc
Celgene Corporation.
Ferring BV.
Bayer AG
Pfizer Inc
AbbVie
Amgen
Janssen Biotech
Allergan, Inc.
Tillotts Pharma
Ferring B.V.
Salix Pharmaceuticals Inc
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Crohn's Disease Market: Technology Type Analysis
-
4.1 Crohn's Disease Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Crohn's Disease Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Aminosalicylates
4.3.2 Corticosteroids
4.3.3 Immunomodulators
5 Crohn's Disease Market: Product Analysis
-
5.1 Crohn's Disease Product Market Share Analysis, 2018 & 2026
-
5.2 Crohn's Disease Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Crohn's Disease Market: Application Analysis
-
6.1 Crohn's Disease Application Market Share Analysis, 2018 & 2026
-
6.2 Crohn's Disease Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Ileocolitis
6.3.2 lleitis
6.3.3 Gastroduodenal Crohn’s disease
6.3.4 Jejunoileitis
6.3.5 Crohn colitis
6.3.6 Others
7 Crohn's Disease Market: Regional Analysis
-
7.1 Crohn's Disease Regional Market Share Analysis, 2018 & 2026
-
7.2 Crohn's Disease Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Johnson & Johnson
9.1.1 Johnson & Johnson Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 Perrigo Company plc
9.2.1 Perrigo Company plc Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 UCB
9.3.1 UCB Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Takeda Pharmaceuticals.
9.4.1 Takeda Pharmaceuticals. Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Prometheus Laboratories Inc
9.5.1 Prometheus Laboratories Inc Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Celgene Corporation.
9.6.1 Celgene Corporation. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Ferring BV.
9.7.1 Ferring BV. Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Bayer AG
9.8.1 Bayer AG Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Pfizer Inc
9.9.1 Pfizer Inc Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 AbbVie
9.10.1 AbbVie Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Amgen
9.11.1 Amgen Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Janssen Biotech
9.12.1 Janssen Biotech Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Allergan, Inc.
9.13.1 Allergan, Inc. Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Tillotts Pharma
9.14.1 Tillotts Pharma Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Ferring B.V.
9.15.1 Ferring B.V. Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Salix Pharmaceuticals Inc
9.16.1 Salix Pharmaceuticals Inc Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
The List of Tables and Figures (Totals 80 Figures and 142 Tables)
Figure Aminosalicylates Crohn's Disease market, 2015 - 2026 (USD Million)
Figure Corticosteroids Crohn's Disease market, 2015 - 2026 (USD Million)
Figure Immunomodulators Crohn's Disease market, 2015 - 2026 (USD Million)
Figure Ileocolitis market, 2015 - 2026 (USD Million)
Figure lleitis market, 2015 - 2026 (USD Million)
Figure Gastroduodenal Crohn’s disease market, 2015 - 2026 (USD Million)
Figure Jejunoileitis market, 2015 - 2026 (USD Million)
Figure Crohn colitis market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Crohn's Disease market, by country, 2015 - 2026 (USD Million)
-
Table North America Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table North America Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table North America Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Canada Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Canada Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Europe Crohn's Disease market, by country, 2015 - 2026 (USD Million)
-
Table Europe Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Europe Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Europe Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Germany Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Germany Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table France Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table France Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Italy Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Italy Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Spain Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Spain Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Crohn's Disease market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table China Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table China Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Japan Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Japan Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table India Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table India Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Crohn's Disease market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table MEA Crohn's Disease market, by country, 2015 - 2026 (USD Million)
-
Table MEA Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table MEA Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table MEA Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Crohn's Disease market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Crohn's Disease market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Crohn's Disease market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Perrigo Company plc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table UCB Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Takeda Pharmaceuticals. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Prometheus Laboratories Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Celgene Corporation. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ferring BV. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AbbVie Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Amgen Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Janssen Biotech Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Allergan, Inc. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Tillotts Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ferring B.V. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Salix Pharmaceuticals Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
